Abstract
Herpes zoster (HZ) is an acute segmental eruption of herpetiform-grouped vesicles due to endogenous reactivation of varicella-zoster virus (VZV) infection of nerval segments. Treatment of choice is systemic acyclovir and other antiviral agents are available. For elderly people, VZV vaccine is an option in secondary prevention.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- BW:
-
Body weight
- DNA pol:
-
DNA polymerase
- HZ:
-
Herpes zoster
- TK:
-
Thymidine kinase
- VZV:
-
Varicella-zoster virus (VZV)
References
Chen N, Yang M, He L, Zhang D, Zhou M, Zhu C. Corticosteroids for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2010;(12):CD005582.
Ono F, Yasumoto S, Furumura M, Hamada T, Ishii N, Gyotoku T, et al. Comparison between famciclovir and valacyclovir for acute pain in adult Japanese immunocompetent patients with herpes zoster. J Dermatol. 2012;39(11):902–8.
Wassilew S, Collaborative Brivudin PHN Study Group. Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study. J Eur Acad Dermatol Venereol. 2005;19(1):47–55.
Further Reading
Baaros GAM, Miot HA, Massarico AM, Ramos F, Borges MA. Topical (S)-ketamine for pain management of postherpetic neuralgia. An Bras Dermatol. 2012;87(3):504–6.
Cousins MJ, Pickthorn K, Huang S, Critchley L, Bell G. The safety and efficacy of KAI-1678 – an inhibitor of epsilon protein kinase C (εPKC) – versus lidocaine and placebo for the treatment of postherpetic neuralgia: A crossover study design. Pain Med. 2013. doi:10.1111/pme.12058.
Drolet M, Oxman MN, Levin MJ, Schmader KE, Johnson RW, Patrick D, Brisson M, et al. Vaccination against herpes zoster in developed countries. State of the evidence. Hum Vaccin Immunother. 2013;9(5):1–8.
Gross G, Schöfer H, Wassilew S, Friese K, Timm A, Guthoff R, et al. Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol. 2003;26(3):277–89.
Molina B, Gonzalez-Vicent M, Albi G, Herrero B, Sevilla J, Diaz MA. Varicella zoster central nervous system vasculitis after allogenic hematopoietic stem cell transplant successfully treated with cyclophosphamide. Transpl Infect Dis. 2012;14(5):E107–10.
Pentikis HS, Matson M, Atiee G, Boehlecke B, Hutchins JT, Patti JM, et al. Pharmacokinetics and safety of FV-100, a novel oral anti-herpes zoster nucleoside analogue, administered in single and multiple doses to healthy young adult and elderly adult volunteers. Antimicrob Agents Chemother. 2011;55(6):2847–54.
Schencking M, Vollbracht C, Weiss G, Lebert J, Biller A, Goyvaerts B, et al. Intravenous vitamin C in the treatment of shingles: results of a multicenter prospective cohort study. Med Sci Monit. 2012;18(4):CR215–24.
Zerngast WW, Paauw DS, O’Connor KM. Varicella zoster with extended prodrome: a case series. Am J Med. 2013;126(4):359–61.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wollina, U. (2015). Herpes Zoster. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D’Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45139-7_39
Download citation
DOI: https://doi.org/10.1007/978-3-662-45139-7_39
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45138-0
Online ISBN: 978-3-662-45139-7
eBook Packages: MedicineMedicine (R0)